Treatment with cisplatin and vinorelbine in patients with squamous cell carcinoma of the head and neck.

被引：0
|
作者：
De la Llaba, J [1 ]
García, AL [1 ]
Aranda, F [1 ]
Barncío, IC [1 ]
Méndez, MI [1 ]
Aranda, E [1 ]
机构：
[1] Hosp Cordoba, Dept Med Oncol, Cordoba, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [41] Cisplatin pharmacokinetics and pharmacodynamics in patients with squamous-cell carcinoma of the head/neck or esophagus
    Johnsson, A
    Hoglund, P
    Grubb, A
    CavallinStahl, E
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 39 (1-2) : 25 - 33
  • [42] Is cetuximab active in patients with cisplatin-refractory squamous cell carcinoma of the head and neck?
    Bonner, J. A.
    Salter, Merle M.
    Keene, K. S.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (12): : 690 - 691
  • [43] Is cetuximab active in patients with cisplatin-refractory squamous cell carcinoma of the head and neck?
    James A Bonner
    Kimberly S Keene
    Nature Clinical Practice Oncology, 2007, 4 : 690 - 691
  • [44] The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma
    A. Al-Mamgani
    M. de Ridder
    A. Navran
    W. M. Klop
    J. P. de Boer
    M. E. Tesselaar
    European Archives of Oto-Rhino-Laryngology, 2017, 274 : 3757 - 3765
  • [45] The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma
    Al-Mamgani, A.
    de Ridder, M.
    Navran, A.
    Klop, W. M.
    de Boer, J. P.
    Tesselaar, M. E.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2017, 274 (10) : 3757 - 3765
  • [46] Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: A multicenter phase II trial
    Gebbia, V
    Mantovani, G
    Agostara, B
    Contu, A
    Farris, A
    Colucci, G
    Cognetti, F
    Restivo, G
    Speciale, R
    Ferrero, B
    Testa, A
    Curreli, L
    Cardinale, A
    Bajetta, E
    Gebbia, N
    ANNALS OF ONCOLOGY, 1995, 6 (10) : 987 - 991
  • [47] Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
    Devleena, Majumdar Anup
    Soumita, Poddar
    Anindya, Chakraborty
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2010, 31 (01) : 4 - 7
  • [48] Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.
    Mork, J
    Lie, AK
    Glattre, E
    Clark, S
    Hallmans, G
    Jellum, E
    Koskela, P
    Moller, B
    Pukkala, E
    Schiller, JT
    Youngman, L
    Lehtinen, M
    Dillner, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (15): : 1125 - 1131
  • [49] Paclitaxel, cisplatin, 5-fluorouracit and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck. A phase II trial
    Merlano, M
    Russi, EG
    Numico, G
    Colantonio, I
    Garrone, O
    Pelissero, A
    Granetto, C
    Gasco, M
    Di Costanzo, G
    Heouaine, A
    Taglianti, RV
    Cipolat, M
    RADIOTHERAPY AND ONCOLOGY, 2005, 75 (02) : 193 - 196
  • [50] HPV status and survival in non-oropharyngeal squamous cell carcinoma of the head and neck.
    Wookey, Vanessa
    Appiah, Adams Kusi
    Kallam, Avyakta
    Ernani, Vinicius
    Smith, Lynette
    Ganti, Apar Kishor
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345